Cresset Asset Management, LLC Seres Therapeutics, Inc. Transaction History

Cresset Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $110,526 - $457,491	-20,243 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$18.46 - $24.36 $98,613 - $130,131	-5,342 Reduced 20.88%	20,243 $483,000
Q1 2021 May 12, 2021	BUY	$17.66 - $28.92 $132,555 - $217,073	7,506 Added 41.52%	25,585 $527,000
Q4 2020 Feb 11, 2021	BUY	$23.25 - $37.73 $86,420 - $140,242	3,717 Added 25.88%	18,079 $443,000
Q3 2020 Nov 13, 2020	BUY	$3.74 - $28.74 $7,839 - $60,239	2,096 Added 17.09%	14,362 $407,000
Q2 2020 Aug 04, 2020	BUY	$3.04 - $6.2 $37,288 - $76,049	12,266 New	12,266 $58,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.